chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HPI: "Patient is a 65 y.o. female with a history of shortness of breath and cough has been present for the last couple weeks she states she's felt better overall for about 6 months has had progressive weight loss over this time but over last week or so she's felt more short of breath increased cough or sputum production low-grade temperature at home has had nausea with decreased appetite denies sick contacts she does have a history of COPD she has a history of smoking quit 6 months ago has been using inhalers at home.  Has felt very sob with ambulation and speaking at times".   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute respiratory failure due to COVID-19 o Pneumonia due to Covid 19 virus with acute respiratory failure with hypoxia. Improving on current treatment. Completed Remdesivir D5/5 course. Continue tapering PO prednisone. Nebs and inhalers as ordered. Weaned off oxygen to RA. Continue nebs and inhalers. Encourage incentive spirometry use and pronating. Continue supportive/symptomatic treatment and supplements as ordered per COVID protocol. Follow up daily lab. Ambulatory care manager referral given on discharge. Follow-up with primary care provider and pulmonary. o MRSA pneumonia. Possible septic emboli with cavitary-type pneumonia. TEE done showing no vegetations. Infectious diseases following and advised IV antibiotic therapy with vancomycin on discharge. PICC line inserted. Follow-up with infectious disease and pulmonary on outpatient basis. o New onset A. fib with RVR. Started on Cardizem drip, converted back to sinus rhythm. Serial troponin remained negative and serum magnesium low, treated with improved level. Cardiology consulted. Advised cardiac stress test and initiation of oral anticoagulation. Eliquis was ordered. Patient refused to have a cardiac stress test done during this hospitalization and requested for it to be done on outpatient basis. She was discharged home accordingly to follow up on the patient with cardiology. Stress test ordered. o Acute kidney injury. Serum creatinine back to baseline at 0.9. Continue to monitor with daily lab. \ o Hypomagnesemia. Treated. Continue to monitor lab closely and treat as needed with IV/oral Mag replacement until normalized. o Elevated d-dimer. CTA of the chest shows no PE and venous ultrasound of the lower extremities shows no DVT. Continue to monitor.  o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.
HEADACHE, NAUSEA, VOMITING, BODY ACHES, RASH
Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via unspecified route of administration in the left arm on 17Mar2021 at 14:45 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, hypertension and known allergies to penicillin (PCN), sulfa, cefadroxil (DURICEF), cephalexin (KEFLEX), soy, dairy and peanuts. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), via unspecified route administration in the left arm on 24Feb2021 at 12:45 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Mar2021 at 13:30, the patient experienced diarrhea and nausea. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events diarrhea and nausea. The clinical outcomes of the events diarrhea and nausea was not recovered at the report.   No follow-up attempts are needed. No further information is expected.
Patient started with a headache on the right side of his head the night he received the vaccine. Friday he started having myoclonic jerks, seizures.  They lasted for hours with no relief until he was put on a low dose of Valium for 3 days.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA 8/10/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 14-OCT-2014 the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 microgram/1 ml (lot # J010613, expiration date 11-JUN-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 48, 1 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Patient reports she felt pain at site of injection (Left arm) when flu vaccine was administered on 1/14/2011.  Pain has continued intermittently. Patient has not sought M.D. care.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 09-OCT-2014, the patient was vaccinated with an improperly stored dose of (23-valent) PNEUMOVAX 0.5 ml (VIs 10 SDV) (Lot number K007822, expiration date 15-AUG-2015), single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, the (23-valent) PNEUMOVAX had temperature excursion for 72 hours, with the lowest recorded temperature of 28F (-2.222 Celsius). The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
fatigue; headache; body ache; My temperature hovered arouund 101.0 F; This is a spontaneous report from a contactable other hcp (patient). A 64-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date (at the age of 64-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Covid-19 from Mar2020. The patient's concomitant medications were not reported. Historical vaccine information included bnt162b2 (COMIRNATY, Solution for injection) 1st dose on 17Dec2020 (at the age 64-years-old) for Covid-19 Immunization and experienced temperature up to 102.2/quite ill with a temperature of 105.1 F, Chills, Numbness in fingertips, Nausea, Soreness in arm, Shaking too badly, Dehydration. The patient experienced fatigue, headache, body ache, my temperature hovered around 101.0 f on an unspecified date. For the second vaccine, patient pre-medicated with Ibuprofen, every 4 hours after the Vaccine patient took TYLENOL or IBUPROFEN. Her temperature hovered around 101.1 F and she continued this for 48 hours and then her temperature started to drop. The other usual complaints of headache, body ache, and fatigue were also present. Again, she was completely well in four days. In her professional opinion, as she was a nurse practitioner, she did not consider this an adverse drug reaction, but just her own body doing what it needed to do. If it was of any interest, she did have Covid in Mar2020. The patient underwent lab tests and procedures which included body temperature resulted in 101.0 fahrenheit on unknown date. Therapeutic measures were taken as a result of events include TYLENOL or IBUPROFEN. The clinical outcome for events was recovered on an unspecified date.   The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Feel weak due to chemotherapy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feel weak due to chemotherapy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Feel weak due to chemotherapy). At the time of the report, ASTHENIA (Feel weak due to chemotherapy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
1) Slight redness in neck/chest area approx. 75 mins after shot 2) Tingling, pins&needles on both sides of face between jaw and cheekbones approx 90 minutes after shot that lasted for about 10-15 minutes. This was followed by numbness around cheekbone area that gradually went away by 4/29/2021 Emergency room doctor gave me antihistamine and I took antihistamine 6 hours later before bedtime and twice the following day. I also used a coldpack on my face. 3) Two days after shot 4/29/2021, slight numbness at tip of my little finger on right hand started in the morning.
Initial and follow up information has been received from a nurse, via the Merck pregnancy registry, concerning a 22 year old female patient, non-smoker with exercise-induced mild asthma (since age 12, no medication), human papilloma virus, and a history of frequent urinary tract infection post-coital, who on 05-FEB-2007 was vaccinated with the first dose, 0.5 ml, of GARDASIL (lot #654510/0962F), and on 17-APR-2007 with the second dose, 0.5 ml, of GARDASIL (lot #654702/0011U). On 07-MAY-2007, the patient had a blood test which confirmed she was pregnant. Date of the LMP and estimated date of conception and delivery were not provided. During pregnancy, the patient took prenatal vitamins PRIMACARE ONE). On 12-JUN-2007, the patient had a Papanicolaou (PAP) test, that revealed atypical squamous cells of undetermined significance (ASCUS), cannot rule out HOSIL (high grade squamous intraepithelial lesion). On 02-JUL-2007 the patient experienced spotting. On 03-JUL-2007, the patient visited the physician was diagnosed with a small subchorionic hemorrhage; an ultrasound indicated she was at 12 weeks, 6 days gestation, with estimated date of confinement of 09-JAN-2008. On 09-JUL-2007, she had an pap smear result of ASCUS, with 2 lesions (Reid's index score 1 lesion at 12, score 2 at 5-6 without Lugol's). A colposcopy was performed, and a biopsy showed cervical intraepithelial neoplasm (CIN) grade 2. On 15-AUG-2007, an ultrasound indicated she was at 18 weeks, 3 days gestation. On 22-OCT-2007, a repeat colposcopy revealed a small focal area 5 o'clock, 3 mm focal area of HPV (right upper inner labia minora). On 05-DEC-2007, the patient was found to be streptococcus B positive, with a note to "treat in labor." On 16-JAN-2008, the patient, with continued CIN II, had a normal spontaneous vaginal delivery, at full-term gestation, and delivered an 8 lb 8 oz, female infant (no complications or abnormalities noted). Beginning after delivery, she experienced "significant symphysitis." In late January 2009 (noted in obstetrician's notes on 01-FEB-2008 as "several days ago"), the patient saw her primary care physician for treatment of a fever up to 104 degrees, which was attributed to flu symptoms; on 01-FEB-2008, she had a normal post partum exam with only some residual symphysis discomfort to palpation. ON 25-FEB-2008, at 6 weeks post partum, the patient had a benign post partum exam, with no complaints and no gross HPV lesions. Additional information is not expected. Follow up from the patient indicated that her baby was healthy and normal and was "doing fine." Additional information has been requested.
My right side where my liver is was so sore I could not touch my whole side. I was in severe pain.
A non-serious spontaneous report of nasal obstruction and dyspnea has been received from a physician concerning a four-year-old male subsequent to FLUMIST. This case is submitted in accordance with MedImmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FLUMIST. The patient's past medical history included rhinitis. His concomitant medications included rhinitis medicine (start year of 2009 - ongoing). The patient received FLUMIST on 29-Oct-2009. On 30-Oct-2009, the patient experienced the events of nasal obstruction and dyspnea which were relieved in a few days. The outcomes of the events were unknown. The reporter assessed the events of nasal obstruction and dyspnea as possibly related to FLUMIST. Additional information was received on 24-Feb-2010 and incorporated into case: lot number.
booster shot at 16:43 - immediately felt dizzy and chest pain/hot. Vital signs normal. At 16:45 Vital signs normal.  Clear lung sounds, unlabored respirations, regular heart rate.  Playing games at 16:45.  At 17:00 No chest discomfort.  Discharged home at 17:10 felt fine.  Patient gets similar symptoms with previous vaccines.
This spontaneous report as received from a other health professional refers to a male patient of unknown age. On an unknown date, the patient was vaccinated with M-M-R II (dose, route and frequency were not reported). On an unknown date, titer done on an unspecified date after this dose of M-M-R II came back low with an unspecified result. On an unknown date in June 2013, another dose of M-M-R II was administered and on an unknown date an unspecified titer result obtained on an unspecified date six months after this dose of M-M-R II was still low for measles. The outcome of the event was unknown. The reporter did not provide the causality between the event and the suspect drug. Additional information has been requested.
Headache , Chills, aches and pains, muscle pains, joint pain. Fatigue , had a fever for  18 hours
Information has been received from a physician concerning an approximately 20 year old female who in 1987 and 1991 was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Recently IGG antibody test showed client is non reactive to measles. The patient sought unspecified medical attention. No further information is available.
Left Cornea is inflamed again after booster dose; Vision is blurry out of her left eye; Left eye is red; Left eye is swollen; This spontaneous case was reported by a consumer and describes the occurrence of KERATITIS (Left Cornea is inflamed again after booster dose), VISION BLURRED (Vision is blurry out of her left eye), OCULAR HYPERAEMIA (Left eye is red) and EYE SWELLING (Left eye is swollen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051F21A) for COVID-19 vaccination.     The patient's past medical history included Corneal disorder NOS (The patient reported that she had a history of Cornea problems starting 40 years ago due to a history of a virus in her eyes.) and Corneal transplant (The patient's past medical history included Corneal transplant two times). Concomitant products included ACICLOVIR and LOTEPREDNOL ETABONATE (LOTEMAX) for an unknown indication.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Nov-2021, the patient experienced KERATITIS (Left Cornea is inflamed again after booster dose), VISION BLURRED (Vision is blurry out of her left eye), OCULAR HYPERAEMIA (Left eye is red) and EYE SWELLING (Left eye is swollen). At the time of the report, KERATITIS (Left Cornea is inflamed again after booster dose), VISION BLURRED (Vision is blurry out of her left eye), OCULAR HYPERAEMIA (Left eye is red) and EYE SWELLING (Left eye is swollen) outcome was unknown.            Treatment  information was not provided.   This case was linked to MOD-2021-391819, MOD-2021-391834 (Patient Link).
Initial information received on 26 June 2009 from a health care professional. A 6 year old female patient received DAPTACEL (lot number, C3082AA) on the right upper thigh on 01 June 2009. Post vaccination the patient developed a red, hot to touch, swollen area of the thigh with discoloration at the site. The site discoloration continues. No further information was provided. Follow up information received on 23 July 2009 from a health care professional. The extent of involvement from the inferior inguinal crease 2 cm to 3 cm above the knee to medial and lateral surfaces. Treatment included Benadryl, Bactrim for 10 days, Rocephin x 1. Office visits were on 03 June 2009, 04 June 2009, and 05 June 2009. Improvement was noted. No further information was provided. Follow-up information received on 21 September 2009 from a health care professional. DAPTACEL had been a fifth series dose and was administered in the patient's right upper thigh. According to the reporter, the events began on 02 June 2009, one day after vaccination. No further information was provided.
nodule development in axilla region, edema to posterior L arm, nausea, achy joints, chills, light headed, malaise
Excessive crying in excess of 20 plus minutes multiple times over course of 48 hours, at the 42 hour mark after receiving vaccines patient started to shake in seizure like manner for roughly 10 minutes before stopping.
Pounding heart in my chest for 3-4 hours at bedtime (11:00pm) before I took a gabapentin to finally fall asleep at 2:45am. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all. However I did take my own heart rate/pulse & it was only in the upper 60s bpm, so I did not go to the ER. But it still felt like my heart was working twice as hard as normal. I woke up feeling very tired, still with a very sore right arm muscle, a bad headache, as well as dizziness. But my heart rate was not elevated in the morning.
CHILLS; HEADACHE; INJECTION SITE SORENESS; CHEST PAIN; SORE ARM; FATIGUE; SLIGHT FEVER; This spontaneous report received from a patient concerned a 21 year old female. The patient's weight was 190 pounds, and height was 158.49 centimeters. The patient's concurrent conditions included smoking, and alcohol user, and other pre-existing medical conditions included patient was not pregnant at the time of reporting and has no history of illicit drug abuse and drug allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 16:30 to left arm for prophylactic vaccination. Non-company suspect drugs included: amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate ( form of admin, route of admin, and batch number were not reported) 15 mg, 2 times every 1 day, therapy dates were not reported for an unspecified indication; and drospirenone/ethinylestradiol ( form of admin, route of admin, and batch number were not reported) dose, frequency, and therapy dates were not reported for an unspecified indication. No concomitant medications were reported. On 10-MAR-2021, the subject experienced chest pain. On 10-MAR-2021, the subject experienced sore arm. On 10-MAR-2021, the subject experienced fatigue. On 10-MAR-2021, the subject experienced slight fever. On an unspecified date, the subject experienced chills, headache, and injection site soreness. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, slight fever, and chest pain, and the outcome of sore arm, headache, chills and injection site soreness was not reported. This report was non-serious.
Expired vaccine was accidently administered. Vaccine was 12 days expired at the time of vaccination. No reports of adverse events, will offer re-vaccination at the recommendation of Moderna
Booster Pfizer 12/02/2021 Fly like symptoms for 3 full days. Fever, chills, aches, nausea, headache 12/08/21 - string asthma like symptoms, tightness in throat, choking feeling, heaviness in chest, ( this comes in huge waves along with rushing nerve pain. I feel breathless when all of this is happening. It?s triggered if I move around too much. Any activity. My digestive system is not acting normal. My food sits in my stomach. All of my insides feel inflamed and tingly.  Severe waves of brain fog. All of my symptoms come in waves and happen 2-3 times per day and then I have times where they calm down. When my symptoms flare it cause panic feelings because of the tightness in my throat. It?s very distressing.  I was treated for possible asthma  due to the  breathing issues. Asthma meds were not relieving my symptoms like they usually would. That?s when I knew something else was going on. My steroid inhaler that she prescribed does seem to calm these odd ?episodes? I?m having and after intake mini breathe better but the tightness is non stop and unrelenting.  I have also had significant bloating in my abdomen that is not normal for me.  On December 23 I developed a rash that turned into blisters. I was diagnosed with shingles. I am 39.  Saw pulmonologist, ENT ( did a scope), and a gastro. Leading up to my shingles diagnoses.  I believe the vaccine brought on shingles for me along with these breathing issues. I feel like I have inflammation in all areas of my body. Even my thinking is effected during the flares.
1/25/22 Pt to ED and admitted to ICU with worsening SOB past 2 days; a week ago, pt had body aches, fever, chills, sweats; in ED found to be positive for COVID; also had blood loss anemia, AKI; poor prognosis; pt passed away in the hospital 2/5/22
Student became hot/pale immediately after injection. He was given a cool towel for his fore head and put his head between his legs x5 min. Regained normal - temp color within 10 min.
No sx. Tested due to being a resident of a long term care facility where there was a current outbreak due to a staff member testing positive during routine testing.
muscle twitching, on her left cheek and between the jaw line area; This is a spontaneous report from a contactable consumer (patient).   A 63-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported), age at vaccination of 63-years-old, as single dose, for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced muscle twitching on left cheek and between the jaw line area non-serious) on an unspecified date almost two weeks after vaccine. Outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.